Northern Trust’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184K Buy
39,513
+1,964
+5% +$7.39K ﹤0.01% 3961
2026
Q1
$113K Hold
37,549
﹤0.01% 4072
2025
Q4
$228K Buy
37,549
+6,629
+21% +$60.3K ﹤0.01% 3934
2025
Q3
$340K Buy
30,920
+12,545
+68% +$111K ﹤0.01% 3787
2025
Q2
$128K Hold
18,375
﹤0.01% 4057
2025
Q1
$66K Hold
18,375
﹤0.01% 4194
2024
Q4
$75.3K Buy
18,375
+2,630
+17% +$9.48K ﹤0.01% 4205
2024
Q3
$48.7K Sell
15,745
-562
-3% -$1.46K ﹤0.01% 4217
2024
Q2
$29.7K Sell
16,307
-63
-0.4% -$107 ﹤0.01% 4289
2024
Q1
$26K Sell
16,370
-70
-0.4% -$136 ﹤0.01% 4311
2023
Q4
$32.7K Hold
16,440
﹤0.01% 4305
2023
Q3
$39.8K Hold
16,440
﹤0.01% 4220
2023
Q2
$47.7K Hold
16,440
﹤0.01% 4231
2023
Q1
$39.9K Hold
16,440
﹤0.01% 4310
2022
Q4
$39.5K Hold
16,440
﹤0.01% 4340
2022
Q3
$44K Hold
16,440
﹤0.01% 4360
2022
Q2
$94K Sell
16,440
-68,670
-81% -$400K ﹤0.01% 4197
2022
Q1
$684K Sell
85,110
-4,443
-5% -$38.3K ﹤0.01% 3606
2021
Q4
$1.04M Sell
89,553
-3,026
-3% -$35.4K ﹤0.01% 3523
2021
Q3
$1.26M Sell
92,579
-4,824
-5% -$64.1K ﹤0.01% 3478
2021
Q2
$1.46M Buy
97,403
+43,784
+82% +$671K ﹤0.01% 3445
2021
Q1
$938K Sell
53,619
-3,623
-6% -$64.6K ﹤0.01% 3612
2020
Q4
$755K Buy
57,242
+57
+0.1% +$805 ﹤0.01% 3611
2020
Q3
$620K Sell
57,185
-3,123
-5% -$40.2K ﹤0.01% 3551
2020
Q2
$748K Buy
60,308
+16,952
+39% +$229K ﹤0.01% 3454
2020
Q1
$691K Buy
43,356
+6,385
+17% +$127K ﹤0.01% 3357
2019
Q4
$939K Buy
+36,971
New +$658K ﹤0.01% 3419

Other funds holding XGN

Northern Trust's XGN Position: Q2 2026 in Review

Northern Trust increased its Exagen (XGN) stake by 5.2% in Q2 2026, buying an estimated $7.39K and bringing the position to 39,513 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3961.

Northern Trust first reported a position in XGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.46M in Q2 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Northern Trust held 39,513 shares of Exagen worth $184K as of Q2 2026.
  • Northern Trust bought 1,964 Exagen shares in Q2 2026, an estimated $7.39K.
  • Exagen made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3961 holding.
  • Northern Trust first reported a position in Exagen in Q4 2019 and has held it in 27 quarters since.
  • Northern Trust's Exagen position peaked at $1.46M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.